Consumer Health Information www.fda.gov consumer Treating Cushing’s Disease in Dogs - FDA Consumer - Document - PDFSEARCH.IO

First Page		Document Content
Anxiety Adrenal gland disorders Endocrine system Glucocorticoids Otologicals Cortisol Trilostane Stress Pituitary adenoma Anatomy Medicine Endocrinology		Consumer Health Information www.fda.gov/consumer Treating Cushing’s Disease in Dogs Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 331,86 KB Share Document on Facebook

	Medical Management of Pituitary-Dependent Hyperadrenocorticism: Mitotane versus Trilostane DocID: 1rRRk - View Document
	Trilostane: A therapeutic consideration for canine hyperadrenocorticism Audrey K Cook Veterinary Medicine; Feb 2008; 103, 2; Career and Technical Education pgReproduced with permission of the copyright owner. Furt DocID: 1qCHM - View Document
	Auburn Endocrine Diagnostic Service ACTH Response Testing in Dogs with Cushing’s Disease treated with TRILOSTANE Periodic ACTH response testing is recommended in all dogs with Cushing’s disease treated with Trilostan DocID: 1k0HY - View Document
	Consumer Health Information www.fda.gov/consumer Treating Cushing’s Disease in Dogs DocID: M9bT - View Document
	Date of Approval: June 5, 2009 FREEDOM OF INFORMATION SUMMARY SUPPLEMENTAL NEW ANIMAL DRUG APPLICATION NADA[removed] DocID: irGZ - View Document